SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-095993
Filing Date
2024-09-03
Accepted
2024-09-03 07:14:05
Documents
16
Period of Report
2024-08-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2422722d1_8k.htm   iXBRL 8-K 33491
2 EXHIBIT 10.1 tm2422722d1_ex10-1.htm EX-10.1 43301
3 EXHIBIT 99.1 tm2422722d1_ex99-1.htm EX-99.1 15089
7 GRAPHIC tm2422722d1_ex99-1img001.jpg GRAPHIC 2116
  Complete submission text file 0001104659-24-095993.txt   289174

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA eyen-20240830.xsd EX-101.SCH 3015
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20240830_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20240830_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2422722d1_8k_htm.xml XML 3676
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 241271889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)